Abstract
Currently, combination therapy, including preoperative irradiation of the tumor and areas of regional lymphatic drainage, has become the standard for the treatment of patients with locally advanced rectal cancer. Methods for evaluating neoadjuvant therapy response are increasingly being introduced into the practice of specialized medical centers. However, the prognostic value of tumor regression grade remains unclear. The results of numerous studies presented in modern literature are contradictory, and their comparative analysis is extremely difficult because of the abundance of post-radiation regression classifications used. This review article reflects the current views on the role and ways of assessing the therapeutic pathomorphosis of rectal cancer after radiotherapy/chemoradiotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
